Small Molecule Agonists of the Orphan Nuclear Receptors Steroidogenic Factor-1 (SF-1, NR5A1) and Liver Receptor Homologue-1 (LRH-1, NR5A2)-Reference-Cited by-同舟云学术

Small Molecule Agonists of the Orphan Nuclear Receptors Steroidogenic Factor-1 (SF-1, NR5A1) and Liver Receptor Homologue-1 (LRH-1, NR5A2)

Published:2011-03-10 Issue:7 Volume:54 Page:2266-2281
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Whitby Richard J.¹,Stec Jozef¹,Blind Raymond D.²,Dixon Sally¹,Leesnitzer Lisa M.³,Orband-Miller Lisa A.³,Williams Shawn P.³,Willson Timothy M.³,Xu Robert³,Zuercher William J.³,Cai Fang²,Ingraham Holly A.²

Affiliation:

1. School of Chemistry, University of Southampton, Southampton, Hants, SO17 1BJ, United Kingdom

2. Department of Cellular and Molecular Pharmacology, Mission Bay Campus, University of California San Francisco, San Francisco, California 94598, United States

3. Molecular Discovery Research, GlaxoSmithKline, 5 Moore Drive, Research Triangle Park, North Carolina 27709-3398, United States

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm1014296

Reference87 articles.

1. Therapeutic potential of nuclear receptors

2. The Nuclear Receptor Superfamily and Drug Discovery

3. Orphan nuclear receptors in drug discovery

4. Orphan Nuclear Receptors as Targets for Drug Development

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bilirubin is a new ligand for nuclear receptor Liver Receptor Homolog-1;2024-05-06

2. Liver receptor homolog-1: structures, related diseases, and drug discovery;Acta Pharmacologica Sinica;2024-04-17

3. The nuclear receptor LRH‐1 discriminates between ligands using distinct allosteric signaling circuits;Protein Science;2023-09-20

4. Steroidogenic Factor-1 form and function: From phospholipids to physiology;Advances in Biological Regulation;2023-09

5. International Union of Basic and Clinical Pharmacology CXIII: Nuclear Receptor Superfamily—Update 2023;Pharmacological Reviews;2023-08-16